STAT

Opinion: Barriers to genomic testing get in the way of precision medicine

In this era of precision medicine, oncologists should be able to quickly check their patients' genomes. I was surprised to learn that many can't.
A lab officer cuts a DNA fragment under UV light from an agarose gel for DNA sequencing as part of research to determine genetic mutation in a blood cancer patient on April 19, 2007 in Singapore.

As precision medicine opens up promising new advances in cancer care, I often think back to my early days as an oncologist, the patients I treated, and the limited treatment options I had for them.

I especially remember Pam (not her real name). She was in her early 30s, recently married, vibrant, and looking forward to a life filled with joy and children. Pam had acute myeloid leukemia, a disease oncologists had struggled to treat for decades. Her leukemia was relentless: Chemotherapy did little to stop it, and it persisted even

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks